145 related articles for article (PubMed ID: 34818475)
1. A Divisive Ruling on Devices -
Zettler PJ; Adashi EY; Cohen IG
N Engl J Med; 2021 Dec; 385(26):2409-2411. PubMed ID: 34818475
[No Abstract] [Full Text] [Related]
2. The FDA, preemption, and the Supreme Court.
Glantz LH; Annas GJ
N Engl J Med; 2008 May; 358(18):1883-5. PubMed ID: 18450601
[No Abstract] [Full Text] [Related]
3. The 21st Century Cures Act.
Calderwood SB; Murray BE; Chambers HF
N Engl J Med; 2015 Oct; 373(17):1679. PubMed ID: 26488713
[No Abstract] [Full Text] [Related]
4. The 21st Century Cures Act.
Kakkis E; Bronstein MG
N Engl J Med; 2015 Oct; 373(17):1678. PubMed ID: 26488712
[No Abstract] [Full Text] [Related]
5. The 21st Century Cures Act.
McClellan MB; Sigal EV
N Engl J Med; 2015 Oct; 373(17):1677-8. PubMed ID: 26488711
[No Abstract] [Full Text] [Related]
6. The 21st Century Cures Act.
Kesselheim AS; Avorn J
N Engl J Med; 2015 Oct; 373(17):1679-80. PubMed ID: 26488710
[No Abstract] [Full Text] [Related]
7. User fees and beyond--the FDA Safety and Innovation Act of 2012.
Kramer DB; Kesselheim AS
N Engl J Med; 2012 Oct; 367(14):1277-9. PubMed ID: 23034017
[No Abstract] [Full Text] [Related]
8. The 21st Century Cures Act: can the regulatory framework survive the "cures"?
Osorio-de-Castro CG; Caetano R; Pepe VL
Cad Saude Publica; 2015 Sep; 31(9):1807-10. PubMed ID: 26578005
[No Abstract] [Full Text] [Related]
9. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914
[No Abstract] [Full Text] [Related]
10. The 21st Century Cures Act--Will It Take Us Back in Time?
Avorn J; Kesselheim AS
N Engl J Med; 2015 Jun; 372(26):2473-5. PubMed ID: 26039522
[No Abstract] [Full Text] [Related]
11. Ethics and the FDA.
Fielder J
IEEE Eng Med Biol Mag; 2006; 25(4):13-7. PubMed ID: 16898653
[No Abstract] [Full Text] [Related]
12. Ejecting the FDA from the courtroom.
Lancet; 2004 Aug 21-27; 364(9435):638. PubMed ID: 15325808
[No Abstract] [Full Text] [Related]
13. FDA reform plan edges closer to realisation.
Marx V
Lancet; 2012 Jun; 379(9832):2135. PubMed ID: 22690392
[No Abstract] [Full Text] [Related]
14. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
Burkhart CG
J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
[No Abstract] [Full Text] [Related]
15. Relocating abroad. FDA sends staff overseas to help monitor imports.
Lee J
Mod Healthc; 2011 Oct; 41(43):32. PubMed ID: 22111150
[No Abstract] [Full Text] [Related]
16. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
Lang L
Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
[No Abstract] [Full Text] [Related]
17. Combination products regulation at the FDA.
Lauritsen KJ; Nguyen T
Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceuticals and medical devices: medical devices.
; Berry MD
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-38. PubMed ID: 22403842
[No Abstract] [Full Text] [Related]
19. Regulation of drugs and devices: an evolution.
Merrill RA
Health Aff (Millwood); 1994; 13(3):47-69. PubMed ID: 7927161
[TBL] [Abstract][Full Text] [Related]
20. Product safety and business interests: deja vu..
Rijswijk L
Ostomy Wound Manage; 2005 Feb; 51(2):8-9. PubMed ID: 15699549
[No Abstract] [Full Text] [Related]
[Next] [New Search]
